{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:11:26Z","timestamp":1783977086188,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejogrb.2026.115246","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:21:05Z","timestamp":1781626865000},"page":"115246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Maternal and perinatal placental dysfunction severity in extremely high values of sFlt1\/PlGF ratio: A retrospective observational study"],"prefix":"10.1016","volume":"324","author":[{"given":"Garance","family":"Devarenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dochez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Thubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Misbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9897-8493","authenticated-orcid":false,"given":"Norbert","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115246_b0005","unstructured":"P.Y. Ancel, Goffinet F,EPIPAGE-2 Writing Group, et al. Survival and morbidity of preterm children born at 22 through 34 weeks\u2019 gestation in France in 2011: results of the EPIPAGE-2 cohort study, JAMA Pediatr 169;2015:230-8."},{"key":"10.1016\/j.ejogrb.2026.115246_b0010","article-title":"Guidelines for the management of women with severe pre-eclampsia","volume":"40","author":"Bonnet","year":"2021","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.ejogrb.2026.115246_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115246_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3343\/alm.2018.38.2.95","article-title":"Evaluation of sFlt-1\/PlGF ratio for predicting and improving clinical management of pre-eclampsia: experience in a specialized perinatal care center","volume":"38","author":"Caillon","year":"2018","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.ejogrb.2026.115246_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jogoh.2017.10.007","article-title":"Angiogenic factors sFlt-1 and PlGF in preeclampsia: prediction of risk and prognosis in a high-risk obstetric population","volume":"47","author":"Tardif","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ejogrb.2026.115246_b0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115246_b0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115246_b0040","unstructured":"National Institute for Health and Care Excellence. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. London: NICE; 2022. Available at: https:\/\/www.nice.org.uk\/guidance\/dg49\/chapter\/1-Recommendations (last accessed 19 December 2022)."},{"key":"10.1016\/j.ejogrb.2026.115246_b0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejogrb.2026.115246_b0050","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2026.115246_b0055","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Schmitz T, Arthuis C, et al. La pr\u00e9-\u00e9clampsie: recommandations pour la pratique clinique du Coll\u00e8ge national des gyn\u00e9cologues obst\u00e9triciens fran\u00e7ais, Gynecol Obstet Fertil Senol 52;2024:3-44.","DOI":"10.1016\/j.gofs.2023.10.002"},{"issue":"45","key":"10.1016\/j.ejogrb.2026.115246_b0060","first-page":"80","article-title":"French College of Fetal Sonography (CFEF), Combourieu D. [Chart for estimation of fetal weight, by the French College of Fetal Sonography (CFEF)]","volume":"2016","author":"Massoud","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.ejogrb.2026.115246_b0065","unstructured":"World Health Organization. WHO Multicentre Growth Reference Study (MGRS). Geneva: WHO. Available at: https:\/\/www.who.int\/tools\/child-growth-standards\/who-multicentre-growth-reference-study (last accessed 22 February 2023)."},{"key":"10.1016\/j.ejogrb.2026.115246_b0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ejogrb.2026.115246_b0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ajcnut.2024.12.001","article-title":"Oral citrulline supplementation in pregnancies with preeclampsia: a multicenter, randomized, double-blind clinical trial","volume":"121","author":"Winer","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejogrb.2026.115246_b0080","doi-asserted-by":"crossref","unstructured":"Dabi Y, Thubert T, Fuchs F, Barjat T, Belaisch-Allart J, Ceccaldi PF. How is functioning the Ethical Review Board 'Comit\u00e9 d\u2019Ethique Pour La Recherche En Obst\u00e9trique Et Gyn\u00e9cologie' (CEROG)? J Gynecol Obstet Hum Reprod 51;2022:102352.","DOI":"10.1016\/j.jogoh.2022.102352"},{"key":"10.1016\/j.ejogrb.2026.115246_b0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115246_b0090","article-title":"Maternal and perinatal outcomes associated with extremely high values for the sFlt\u20101 (soluble fms\u2010like tyrosine kinase 1)\/PlGF (placental growth factor) ratio","volume":"9","author":"Villala\u00edn","year":"2020","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"10.1016\/j.ejogrb.2026.115246_b0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preghy.2018.01.001","article-title":"An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia","volume":"11","author":"Stolz","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2026.115246_b0100","article-title":"Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small\u2010for\u2010gestational\u2010age infants","volume":"5","author":"Heazell","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"58","key":"10.1016\/j.ejogrb.2026.115246_b0105","first-page":"e1","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115246_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.103120","article-title":"Implementation of placental growth factor in a tertiary western Canadian centre: association with ultrasound findings and perinatal outcomes","volume":"47","author":"Figueiro-Filho","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2026.115246_b0115","article-title":"First trimester PlGF and PAPP-A and the risk of placenta-mediated complications: PREDICTION prospective study","volume":"47","author":"C\u00f4t\u00e9","year":"2025","journal-title":"J Obstet Gynaecol Can"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:28:14Z","timestamp":1783974494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"alternative-id":["S0301211526003143"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115246","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal and perinatal placental dysfunction severity in extremely high values of sFlt1\/PlGF ratio: A retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115246"}}